INHIBITORS OF COLLAGEN-INDUCED PLATELET AGGREGATION

摘要

The present invention describes a therapeutic method useful for treating or preventing a condition of platelet aggregation, in a subject including administering a pharmaceutically effective amount of a compound or composition that inhibits BTK and collagen induced platelet aggregation. The condition of platelet aggregation includes cardiovascular, hematopoietic and cerbrovascular diseases.